Clinical and Genetic Features in Two Families With MELAS and the T3271C Mutation in Mitochondrial DNA

Abstract

The majority of patients with MELAS (mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes) have the A3243G point mutation. The much rarer T3271C mutation has been reported predominantly in Japanese subjects. Our objective was to better define the clinical phenotype and mutation load in patients with MELAS and the T3271C mutation in mitochondrial DNA. We present clinical and molecular genetic data in two pedigrees with the T3271C mutation. The age at onset was 8 years in one proband and 14 years in the other. Both patients had migrainelike headache, seizures, and strokelike episodes. Mutation loads were quantified in multiple tissues from the patients and from family members by polymerase chain reaction—restriction fragment length polymorphism analysis. The symptoms in both probands were typical of MELAS, and, contrary to previous reports, onset was early. Hearing loss was less common than in typical MELAS, and ragged red fibers were absent. The proportion of mutant genomes was consistently and markedly greater in DNA from urinary sediment than from blood. In the mother of one proband, mutant genomes were detected only in DNA from hair follicles and cheek mucosa. The phenotype of patients with the T3271C mutation might not be as distinct as that of the A3243G mutation, as previously described. Our data also suggest that urine is a better source of DNA than blood for diagnosis and that multiple tissues should be studied in maternal relatives, especially when the mutation cannot be detected in blood. (J Child Neurol 2005;20:142—146).

Get full access to this article

View all access options for this article.

References

Goto Y. , Horai S. , Matsuoka T. , et al: Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): A correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992;42:545—550.

Goto Y. , Nonaka I. , Horai S. : A mutation in the tRNALeu(UUR) gene assoc i a t e d w i t h t h e M E L A S s u b g r o u p i n mitochondrial encephalopathies. Nature 1990;348:651—653.

Goto Y. , Nonaka I. , Horai S. : A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta 1991; 1097:238—240.

Goto Y. : Clinical features of MELAS and mitochondrial DNA mutations. Muscle Nerve 1995;3:S105—S112.

Tarnopolsky MA , Maguire J. , Myint T. , et al: Clinical, physiological and histological features in a kindred with the T3271C MELAS mutation. Muscle Nerve 1998;21:25—33.

Marie Skn , Goto Y. , Passos-Bueno MR et al: A Caucasian family with the 3271 mutation in mitochondrial DNA . Biochem Med Metab Biol 1994;52:136—139.

Sakuta R. , Goto Y. , Horai S. , Nonaka I. : Mitochondrial DNA mutations at nucleotide positions 3243 and 3271 in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: A comparative study. J Neurol Sci 1993;115:158—160.

Barisic N. , Kleiner IM , Malcic I. , et al: Spinal dysraphism associated with congenital heart disorder in a girl with MELAS syndrome and point mutation at mitochondrial DNA nucleotide 3271. Croatian Med J 2002;43:37—41.

Tsukuda K. , Suzuki Y. , Kameoka K. , et al: Screening of patients with maternally transmitted diabetes for mitochondrial gene mutations in the tRNALeu(UUR) region. Diabet Med 1997; 14:1033—1037.

10.

Suzuki Y. , Tsukuda K. , Taniyama M. , et al: Lipoma and sensory neuropathy in mitochondrial diabetes associated with tRNA mutation at position 3271. Diabetes Care 2002;25:407.

11.

Nagashima T. , Kato H. , Maguchi S. , et al: A mitochondrial encephalomyo-neuropathy with a nucleotide position (T-C) point mutation in the mitochondrial DNA. Neuromusc Disord 2001;11:470—476.

12.

Sambrook J. , Russell DW : Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 2001, 6.4—6.11.

13.

Park H. , Davidson E. , King MP : The pathogenic A3243G mutation in human mitochondrial tRNALeu(UUR) decreases the efficiency of aminoacylation. Biochemistry 2003;42:958—964.